Cloevis is a new, low cost and effective method of preventing sewer corrosion and odours caused by hydrogen sulfide. An estimated US$14B is spent on sewer corrosion every year in the US. Current chemical treatments target the hydrogen sulfide and therefore require continuous dosing leading to high operating costs.
Cloevis is a two part solution, a patent pending chemical mix that is able to effectively kill sulfate-reducing bacteria and a software modelling tool used to optimise dosing. This delivers a lower cost solution than existing treatments.
Cloevis is based on technologies developed at the Advanced Water Management Centre at The University of Queensland and comes from over 10 years of research sponsored by most of the major Australian water utilities. Cloevis is being managed by UniQuest Pty Ltd, one of Australia’s leading technology transfer companies.
Join us at www.cloevis.com
Tony Keating is the Program Manager for Cloevis, a University of Queensland spin-off project that delivers low cost and effective prevention of sewer corrosion and odours. Tony is an Associate at UniQuest Pty Ltd, one of Australia’s leading research technology transfer companies. UniQuest is best known for its role in the development of the cervical cancer vaccine Gardasil. At UniQuest, Tony specialises in early-stage energy, cleantech and software technologies from major Australian universities and institutes.
Tony joined UniQuest from Exa Corporation where he worked in senior business development and engineering management roles. Based in Boston, Exa Corporation is an MIT spin-off company providing fluids simulation driven design tools to the automotive, aerospace and military markets.
Tony received his PhD, Master’s and Bachelor’s degrees in Mechanical Engineering from The University of Queensland. He completed an Executive Certificate in Management and Leadership at the MIT Sloan School of Management in 2009.
